E2F2.md
... ...
@@ -1,5 +1,12 @@
1 1
# E2F2
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2022-07-06 : Burkhardt : BL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -38,3 +45,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
38 45
![image](images/gene_expression/E2F2_by_pathology.svg)
39 46
<!-- ORIGIN: burkhardtClinicalRelevanceMolecular2022b -->
40 47
<!-- BL: burkhardtClinicalRelevanceMolecular2022b -->
48
+## References
49
+1. Burkhardt B, Michgehl U, Rohde J, Erdmann T, Berning P, Reutter K, Rohde M, Borkhardt A, Burmeister T, Dave S, Tzankov A, Dugas M, Sandmann S, Fend F, Finger J, Mueller S, Gökbuget N, Haferlach T, Kern W, Hartmann W, Klapper W, Oschlies I, Richter J, Kontny U, Lutz M, Maecker-Kolhoff B, Ott G, Rosenwald A, Siebert R, von Stackelberg A, Strahm B, Woessmann W, Zimmermann M, Zapukhlyak M, Grau M, Lenz G. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nat Commun. 2022 Jul 6;13(1):3881. PMCID: PMC9259584
EDNRB.md
... ...
@@ -1,5 +1,12 @@
1 1
# EDNRB
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2022-07-06 : Burkhardt : BL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -38,3 +45,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
38 45
![image](images/gene_expression/EDNRB_by_pathology.svg)
39 46
<!-- ORIGIN: burkhardtClinicalRelevanceMolecular2022b -->
40 47
<!-- BL: burkhardtClinicalRelevanceMolecular2022b -->
48
+## References
49
+1. Burkhardt B, Michgehl U, Rohde J, Erdmann T, Berning P, Reutter K, Rohde M, Borkhardt A, Burmeister T, Dave S, Tzankov A, Dugas M, Sandmann S, Fend F, Finger J, Mueller S, Gökbuget N, Haferlach T, Kern W, Hartmann W, Klapper W, Oschlies I, Richter J, Kontny U, Lutz M, Maecker-Kolhoff B, Ott G, Rosenwald A, Siebert R, von Stackelberg A, Strahm B, Woessmann W, Zimmermann M, Zapukhlyak M, Grau M, Lenz G. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nat Commun. 2022 Jul 6;13(1):3881. PMCID: PMC9259584
EIF2AK4.md
... ...
@@ -1,5 +1,12 @@
1 1
# EIF2AK4
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2014-05-08 : Zhang : MCL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -21,10 +28,6 @@
21 28
|FL |No |No |0.000 |0 |
22 29
23 30
24
-> [!NOTE]
25
-> First described in MCL in 2014 by [Zhang J](https://pubmed.ncbi.nlm.nih.gov/24682267)
26
-
27
-
28 31
View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/EIF2AK4_protein.html) or [hg38](https://morinlab.github.io/LLMPP/GAMBL/EIF2AK4_protein_hg38.html)
29 32
30 33
![image](images/proteinpaint/EIF2AK4_NM_001013703.svg)
... ...
@@ -36,3 +39,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
36 39
![image](images/gene_expression/EIF2AK4_by_pathology.svg)
37 40
<!-- ORIGIN: zhangGenomicLandscapeMantle2014 -->
38 41
<!-- MCL: zhangGenomicLandscapeMantle2014 -->
42
+## References
43
+1. Zhang J, Jima D, Moffitt AB, Liu Q, Czader M, Hsi ED, Fedoriw Y, Dunphy CH, Richards KL, Gill JI, Sun Z, Love C, Scotland P, Lock E, Levy S, Hsu DS, Dunson D, Dave SS. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells. Blood. 2014 May 8;123(19):2988–2996.
EIF2C4.md
... ...
@@ -1,5 +1,12 @@
1 1
# EIF2C4
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2012-12-01 : Love : BL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -32,3 +39,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
32 39
![image](images/gene_expression/EIF2C4_by_pathology.svg)
33 40
<!-- ORIGIN: loveGeneticLandscapeMutations2012 -->
34 41
<!-- BL: loveGeneticLandscapeMutations2012 -->
42
+## References
43
+1. Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WWL, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012 Dec;44(12):1321–1325. PMCID: PMC3674561
EIF4A1.md
... ...
@@ -1,5 +1,12 @@
1 1
# EIF4A1
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2019-09-26 : Panea : BL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -23,10 +30,6 @@
23 30
|FL |No |No |0.000 |0 |
24 31
25 32
26
-> [!NOTE]
27
-> First described in BL in 2019 by [Panea RI](https://pubmed.ncbi.nlm.nih.gov/31558468)
28
-
29
-
30 33
View coding variants in ProteinPaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/EIF4A1_protein.html) or [hg38](https://morinlab.github.io/LLMPP/GAMBL/EIF4A1_protein_hg38.html)
31 34
32 35
![image](images/proteinpaint/EIF4A1_NM_001416.svg)
... ...
@@ -38,3 +41,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
38 41
![image](images/gene_expression/EIF4A1_by_pathology.svg)
39 42
<!-- ORIGIN: paneaWholeGenomeLandscape2019 -->
40 43
<!-- BL: paneaWholeGenomeLandscape2019 -->
44
+## References
45
+1. Panea R, Love C, Shingleton JR, Reddy A, Bailey J, Moormann A, Otieno J, Ong’echa J, Oduor C, Schroêder K, Masalu N, Chao N, Agajanian M, Major M, Fedoriw Y, Richards K, Rymkiewicz G, Miles R, Alobeid B, Bhagat G, Flowers C, Ondrejka S, Hsi E, Choi W, Au-Yeung R, Hartmann W, Lenz G, Meyerson H, Lin YY, Zhuang Y, Luftig M, Waldrop A, Dave T, Thakkar D, Sahay H, Li G, Palus B, Seshadri V, Kim S, Gascoyne R, Levy S, Mukhopadhyay M, Dunson D, Dave S. The whole genome landscape of Burkitt lymphoma subtypes. Blood. 2019;
EML2.md
... ...
@@ -1,5 +1,12 @@
1 1
# EML2
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2012-12-01 : Love : BL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -38,3 +45,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
38 45
![image](images/gene_expression/EML2_by_pathology.svg)
39 46
<!-- ORIGIN: loveGeneticLandscapeMutations2012 -->
40 47
<!-- BL: loveGeneticLandscapeMutations2012 -->
48
+## References
49
+1. Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WWL, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012 Dec;44(12):1321–1325. PMCID: PMC3674561
ENTPD3.md
... ...
@@ -1,5 +1,12 @@
1 1
# ENTPD3
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2012-12-01 : Love : BL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -38,3 +45,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
38 45
![image](images/gene_expression/ENTPD3_by_pathology.svg)
39 46
<!-- ORIGIN: loveGeneticLandscapeMutations2012 -->
40 47
<!-- BL: loveGeneticLandscapeMutations2012 -->
48
+## References
49
+1. Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WWL, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012 Dec;44(12):1321–1325. PMCID: PMC3674561
EPHB2.md
... ...
@@ -1,5 +1,13 @@
1 1
# EPHB2
2
+## History
2 3
4
+
5
+```mermaid
6
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
7
+timeline
8
+ title Publication timing
9
+ 2012-12-01 : Love : BL
10
+```
3 11
## Relevance tier by entity
4 12
5 13
|Entity|Tier|Description |
... ...
@@ -38,3 +46,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
38 46
![image](images/gene_expression/EPHB2_by_pathology.svg)
39 47
<!-- ORIGIN: loveGeneticLandscapeMutations2012 -->
40 48
<!-- BL: loveGeneticLandscapeMutations2012 -->
49
+## References
50
+1. Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WWL, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012 Dec;44(12):1321–1325. PMCID: PMC3674561
EPPK1.md
... ...
@@ -1,5 +1,12 @@
1 1
# EPPK1
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2019-09-26 : Panea : BL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -23,10 +30,6 @@
23 30
|FL |No |No |2.802 |0.0 |
24 31
25 32
26
-> [!NOTE]
27
-> First described in BL in 2019 by [Panea RI](https://pubmed.ncbi.nlm.nih.gov/31558468)
28
-
29
-
30 33
## EPPK1 Hotspots
31 34
32 35
| Chromosome |Coordinate (hg19) | ref>alt | HGVSp |
... ...
@@ -44,3 +47,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
44 47
![image](images/gene_expression/EPPK1_by_pathology.svg)
45 48
<!-- ORIGIN: paneaWholeGenomeLandscape2019 -->
46 49
<!-- BL: paneaWholeGenomeLandscape2019 -->
50
+## References
51
+1. Panea R, Love C, Shingleton JR, Reddy A, Bailey J, Moormann A, Otieno J, Ong’echa J, Oduor C, Schroêder K, Masalu N, Chao N, Agajanian M, Major M, Fedoriw Y, Richards K, Rymkiewicz G, Miles R, Alobeid B, Bhagat G, Flowers C, Ondrejka S, Hsi E, Choi W, Au-Yeung R, Hartmann W, Lenz G, Meyerson H, Lin YY, Zhuang Y, Luftig M, Waldrop A, Dave T, Thakkar D, Sahay H, Li G, Palus B, Seshadri V, Kim S, Gascoyne R, Levy S, Mukhopadhyay M, Dunson D, Dave S. The whole genome landscape of Burkitt lymphoma subtypes. Blood. 2019;
ERAP1.md
... ...
@@ -1,5 +1,12 @@
1 1
# ERAP1
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2022-07-06 : Burkhardt : BL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -38,3 +45,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
38 45
![image](images/gene_expression/ERAP1_by_pathology.svg)
39 46
<!-- ORIGIN: burkhardtClinicalRelevanceMolecular2022b -->
40 47
<!-- BL: burkhardtClinicalRelevanceMolecular2022b -->
48
+## References
49
+1. Burkhardt B, Michgehl U, Rohde J, Erdmann T, Berning P, Reutter K, Rohde M, Borkhardt A, Burmeister T, Dave S, Tzankov A, Dugas M, Sandmann S, Fend F, Finger J, Mueller S, Gökbuget N, Haferlach T, Kern W, Hartmann W, Klapper W, Oschlies I, Richter J, Kontny U, Lutz M, Maecker-Kolhoff B, Ott G, Rosenwald A, Siebert R, von Stackelberg A, Strahm B, Woessmann W, Zimmermann M, Zapukhlyak M, Grau M, Lenz G. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nat Commun. 2022 Jul 6;13(1):3881. PMCID: PMC9259584
ESX1.md
... ...
@@ -1,5 +1,12 @@
1 1
# ESX1
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2014-05-08 : Zhang : MCL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -36,3 +43,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
36 43
![image](images/gene_expression/ESX1_by_pathology.svg)
37 44
<!-- ORIGIN: zhangGenomicLandscapeMantle2014 -->
38 45
<!-- MCL: zhangGenomicLandscapeMantle2014 -->
46
+## References
47
+1. Zhang J, Jima D, Moffitt AB, Liu Q, Czader M, Hsi ED, Fedoriw Y, Dunphy CH, Richards KL, Gill JI, Sun Z, Love C, Scotland P, Lock E, Levy S, Hsu DS, Dunson D, Dave SS. The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells. Blood. 2014 May 8;123(19):2988–2996.
ETV6.md
... ...
@@ -1,7 +1,14 @@
1 1
# ETV6
2 2
## Overview
3 3
ETV6 is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) affected by aberrant somatic hypermutation in B-cell lymphomas, which complicates the interpretation of mutations at this locus. The prevalence of mutations in DLBCL has varied across different studies and may occur in as many as 10% of patients. This gene has some recurrent sites of mutations (hot spots) including multiple mutations predicted to affect splicing of ETV6 pre-mRNA. The mutation pattern in DLBCL mplies the preferential accumulation of *inactivating mutations*. Coding and non-coding mutations in this gene are associated with the MCD genetic subgroup of DLBCL.
4
-
4
+## History
5
+
6
+```mermaid
7
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
8
+timeline
9
+ title Publication timing
10
+ 2018-10-01 : Arthur : DLBCL
11
+```
5 12
## Relevance tier by entity
6 13
7 14
|Entity|Tier|Description |
... ...
@@ -52,3 +59,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
52 59
![image](images/gene_expression/ETV6_by_pathology.svg)
53 60
<!-- ORIGIN: arthurGenomewideDiscoverySomatic2018 -->
54 61
<!-- DLBCL: arthurGenomewideDiscoverySomatic2018 -->
62
+## References
63
+1. Arthur SE, Jiang A, Grande BM, Alcaide M, Cojocaru R, Rushton CK, Mottok A, Hilton LK, Lat PK, Zhao EY, Culibrk L, Ennishi D, Jessa S, Chong L, Thomas N, Pararajalingam P, Meissner B, Boyle M, Davidson J, Bushell KR, Lai D, Farinha P, Slack GW, Morin GB, Shah S, Sen D, Jones SJM, Mungall AJ, Gascoyne RD, Audas TE, Unrau P, Marra MA, Connors JM, Steidl C, Scott DW, Morin RD. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma. Nat Commun. 2018 Oct 1;9(1):4001. PMCID: PMC6167379
EWSR1.md
... ...
@@ -1,9 +1,16 @@
1 1
# EWSR1
2 2
3
+```mermaid
4
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
5
+timeline
6
+ title Publication timing
7
+ 2020-07-30 : Pararajalingam : MCL
8
+```
3 9
## Relevance tier by entity
4 10
5 11
|Entity|Tier|Description |
6 12
|:------:|:----:|------------------------|
13
+|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene|
7 14
|![MCL](images/icons/MCL_tier1.png) |1 |high-confidence MCL gene|
8 15
9 16
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
... ...
@@ -36,3 +43,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
36 43
![image](images/gene_expression/EWSR1_by_pathology.svg)
37 44
<!-- ORIGIN: pararajalingamCodingNoncodingDrivers2020 -->
38 45
<!-- MCL: pararajalingamCodingNoncodingDrivers2020 -->
46
+## References
47
+1. Pararajalingam P, Coyle KM, Arthur SE, Thomas N, Alcaide M, Meissner B, Boyle M, Qureshi Q, Grande BM, Rushton C, Slack GW, Mungall AJ, Tam CS, Agarwal R, Dawson SJ, Lenz G, Balasubramanian S, Gascoyne RD, Steidl C, Connors J, Villa D, Audas TE, Marra MA, Johnson NA, Scott DW, Morin RD. Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing. Blood. 2020 Jul 30;136(5):572–584. PMCID: PMC7440974
EXOSC6.md
... ...
@@ -1,5 +1,11 @@
1 1
# EXOSC6
2
-
2
+## History
3
+```mermaid
4
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
5
+timeline
6
+ title Publication timing
7
+ 2012-10-04 : Schmitz : BL
8
+```
3 9
## Relevance tier by entity
4 10
5 11
|Entity|Tier|Description |
... ...
@@ -38,3 +44,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
38 44
![image](images/gene_expression/EXOSC6_by_pathology.svg)
39 45
<!-- ORIGIN: schmitzBurkittLymphomaPathogenesis2012 -->
40 46
<!-- BL: schmitzBurkittLymphomaPathogenesis2012 -->
47
+## References
48
+1. Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, Wright G, Shaffer AL, Hodson DJ, Buras E, Liu X, Powell J, Yang Y, Xu W, Zhao H, Kohlhammer H, Rosenwald A, Kluin P, Müller-Hermelink HK, Ott G, Gascoyne RD, Connors JM, Rimsza LM, Campo E, Jaffe ES, Delabie J, Smeland EB, Ogwang MD, Reynolds SJ, Fisher RI, Braziel RM, Tubbs RR, Cook JR, Weisenburger DD, Chan WC, Pittaluga S, Wilson W, Waldmann TA, Rowe M, Mbulaiteye SM, Rickinson AB, Staudt LM. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012 Oct 4;490(7418):116–120. PMCID: PMC3609867
EZR.md
... ...
@@ -1,5 +1,12 @@
1 1
# EZR
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2019-08-20 : Desch : PMBL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -42,3 +49,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/E
42 49
![image](images/gene_expression/EZR_by_pathology.svg)
43 50
<!-- ORIGIN: deschGenotypingCirculatingTumor2020 -->
44 51
<!-- PMBL: deschGenotypingCirculatingTumor2020 -->
52
+## References
53
+1. Desch AK, Hartung K, Botzen A, Brobeil A, Rummel M, Kurch L, Georgi T, Jox T, Bielack S, Burdach S, Classen CF, Claviez A, Debatin KM, Ebinger M, Eggert A, Faber J, Flotho C, Frühwald M, Graf N, Jorch N, Kontny U, Kramm C, Kulozik A, Kühr J, Sykora KW, Metzler M, Müller HL, Nathrath M, Nüßlein T, Paulussen M, Pekrun A, Reinhardt D, Reinhard H, Rössig C, Sauerbrey A, Schlegel PG, Schneider DT, Scheurlen W, Schweigerer L, Simon T, Suttorp M, Vorwerk P, Schmitz R, Kluge R, Mauz-Körholz C, Körholz D, Gattenlöhner S, Bräuninger A. Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma. Leukemia. 2020 Jan;34(1):151–166. PMID: 31431735
FAM129B.md
... ...
@@ -1,5 +1,12 @@
1 1
# FAM129B
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2012-12-01 : Love : BL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -36,3 +43,5 @@ View all variants in GenomePaint [hg19](https://morinlab.github.io/LLMPP/GAMBL/F
36 43
![image](images/gene_expression/FAM129B_by_pathology.svg)
37 44
<!-- ORIGIN: loveGeneticLandscapeMutations2012 -->
38 45
<!-- BL: loveGeneticLandscapeMutations2012 -->
46
+## References
47
+1. Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, Richards KL, Dunphy CH, Choi WWL, Srivastava G, Lugar PL, Rizzieri DA, Lagoo AS, Bernal-Mizrachi L, Mann KP, Flowers CR, Naresh KN, Evens AM, Chadburn A, Gordon LI, Czader MB, Gill JI, Hsi ED, Greenough A, Moffitt AB, McKinney M, Banerjee A, Grubor V, Levy S, Dunson DB, Dave SS. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012 Dec;44(12):1321–1325. PMCID: PMC3674561
FAM38B.md
... ...
@@ -1,5 +1,12 @@
1 1
# FAM38B
2
-
2
+## History
3
+
4
+```mermaid
5
+%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
6
+timeline
7
+ title Publication timing
8
+ 2013-08-15 : Morin : DLBCL
9
+```
3 10
## Relevance tier by entity
4 11
5 12
|Entity|Tier|Description |
... ...
@@ -26,3 +33,5 @@
26 33
![image](images/gene_expression/FAM38B_by_pathology.svg)
27 34
<!-- ORIGIN: morinMutationalStructuralAnalysis2013 -->
28 35
<!-- DLBCL: morinMutationalStructuralAnalysis2013 -->
36
+## References
37
+1. Morin RD, Mungall K, Pleasance E, Mungall AJ, Goya R, Huff RD, Scott DW, Ding J, Roth A, Chiu R, Corbett RD, Chan FC, Mendez-Lago M, Trinh DL, Bolger-Munro M, Taylor G, Hadj Khodabakhshi A, Ben-Neriah S, Pon J, Meissner B, Woolcock B, Farnoud N, Rogic S, Lim EL, Johnson NA, Shah S, Jones S, Steidl C, Holt R, Birol I, Moore R, Connors JM, Gascoyne RD, Marra MA. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing. Blood. 2013 Aug 15;122(7):1256–1265. PMCID: PMC3744992